ZenNews› Health› AI-Built Viruses Put U.S. Biosafety Oversight to … Health AI-Built Viruses Put U.S. Biosafety Oversight to the Test Senate labs panel eyes new review rules as synthetic pathogen count rises By Oliver Walsh Aug 17, 2026 1 min read Updated: Aug 18, 2026 Share Share X Facebook WhatsApp Copy link How do you feel about this? 🔥 0 😲 0 🤔 0 👍 0 😢 0 Health Built Viruses Put Biosafety O Oliver Walsh Health & Climate Oliver Walsh analyses medical research, US health policy and climate science. You might also like › Health mRNA Cancer Vaccine Trial Stirs U.S. Biotech Investment Rush 01 Sep 2026 Health Pig Kidney Record Puts Xenotransplant Policy in Congress 08 Sep 2026 Health Pig Kidney Milestone Shifts U.S. Transplant Donor Debate 08 Sep 2026 Health Black Market Retatrutide Floods U.S. as FDA Approval Lags 07 Sep 2026 Health FDA Weighs Urine Cancer Test That Rivals Invasive Methods 03 Sep 2026 Health FDA Eyes Hot Beverage Cancer Link as Labeling Gap Widens 11 Sep 2026 Also interesting › Society War Readiness Rhetoric Exposes Gaps in US Mental Health Prep 20 hrs ago Economy AI Giants' Merch Lines Test Silicon Valley Brand Strategy Yesterday World Fed's Unanimous Hike Defies Trump, Tests Bank Independence Yesterday Tech Altman's 'Trust Us' Pitch Meets Skepticism on Capitol Hill 16 Sep 2026 More in Health › Health Weight-Loss Drug Shortage Fuels Counterfeit Crisis Across U.S. 11 Sep 2026 Health FDA Eyes Hot Beverage Cancer Link as Labeling Gap Widens 11 Sep 2026 Health Hot Beverage Warning Puts FDA's Labeling Rules in Spotlight 10 Sep 2026 Health Pig Kidney Record Puts Xenotransplant Policy in Congress 08 Sep 2026 ← Health AI-Designed Virus Research Splits U.S. Biosecurity Funding Debate Health → Weekly Insulin Shot Fuels U.S. Push to Simplify Diabetes Care
